Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Gorka Barrenetxea, Cora Hernández, Julio Herrero, Luis Martínez Navarro, Manuel Muñoz, José María Rubio, Fernando Sánchez & Jesús Zabaleta. (2023) Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus. Journal of Obstetrics and Gynaecology 43:1.
Read now
Read now
Helen Saunders, Linda Bjärgestad Lamp, Hasan Donat, Monja Messner, Maren Reder & Helen Kendrew. (2021) Risk of dosing errors in ART treatment: user experience of single- vs multi-use follitropin alfa pens. Expert Opinion on Drug Delivery 18:5, pages 643-654.
Read now
Read now
Helen Saunders, Laura de la Fuente Bitaine, Chriss Eftekhar, Colin M. Howles, Johanna Glaser, Tina Hoja & Pablo Arriagada. (2018) Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses. Expert Opinion on Drug Delivery 15:6, pages 549-558.
Read now
Read now
John L Yovich, Birgit Alsbjerg, Jason L Conceicao, Peter M Hinchliffe & Kevin N Keane. (2016) PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome. Drug Design, Development and Therapy 10, pages 2561-2573.
Read now
Read now
Olaf GJ Naether, Andreas Tandler-Schneider & Wilma Bilger. (2015) Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice. Drug, Healthcare and Patient Safety 7, pages 69-76.
Read now
Read now
Xiaoxiao Guo, Hao Zhan, Xianghui Zhang, Yiwei Pang, Huishu Xu, Baolin Zhang, Kaixue Lao, Peihui Ding, Yanlin Wang & Lei Han. Predictive models for starting dose of gonadotropin in controlled ovarian hyperstimulation: review and progress update. Human Fertility 0:0, pages 1-8.
Read now
Read now
Articles from other publishers (56)
Nuria Correa, Jesus Cerquides, Rita Vassena, Mina Popovic & Josep Lluis Arcos. (2024) IDoser: Improving individualized dosing policies with clinical practice and machine learning. Expert Systems with Applications 238, pages 121796.
Crossref
Crossref
Eduardo Hariton, Zoran Pavlovic, Michael Fanton & Victoria S. Jiang. (2023) Applications of artificial intelligence in ovarian stimulation: a tool for improving efficiency and outcomes. Fertility and Sterility 120:1, pages 8-16.
Crossref
Crossref
Huiyu Xu, Guoshuang Feng, Yong Han, Antonio La Marca, Rong Li & Jie Qiao. (2023) POvaStim: An online tool for directing individualized FSH doses in ovarian stimulation. The Innovation, pages 100401.
Crossref
Crossref
Paul Barrière, Samir Hamamah, Elisangela Arbo, Catherine Avril, Bruno Salle, Jean-Luc Pouly, Julian Jenkins, Collaborators - Members of the REOLA Study Group: Sylvia Alvarez, Tal Anahory, Samir Hamamah, François-Xavier Aubriot, Nadia Kazdar, Catherine Avril, Véronika Grzegorczyk-Martin, Paul Barrière, Joelle Belaisch-Allart, Véronique Chabert-Orsini, Géraldine Porcu-Buisson, Charles Chapron, Blandine Courbiere, Christine Decanter, Michael Grynberg, Claude Hocké, Nathalie Massin, Isabelle Parneix, Jean-Luc Pouly, Paul Sagot & Bruno Salle Bruno. (2023) A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose. Journal of Gynecology Obstetrics and Human Reproduction 52:1, pages 102510.
Crossref
Crossref
Masato Kobanawa. (2023) The gonadotropins starting dose calculator, which can be adjusted the target number of oocytes and stimulation duration days to achieve individualized controlled ovarian stimulation in Japanese patients. Reproductive Medicine and Biology 22:1.
Crossref
Crossref
Bum Chae Choi, Canquan Zhou, Hong Ye, Yun Sun, Ying Zhong, Fei Gong, Ivan Sini, Nadezda Abramova, Salvatore Longobardi, Miranda Hickey & Thomas D’Hooghe. (2022) A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study. Reproductive Biology and Endocrinology 20:1.
Crossref
Crossref
Geeta Nargund, Adrija Kumar Datta, Stuart Campbell, Pasquale Patrizio, Ri-Cheng Chian, Willem Ombelet, Michael Von Wolff, Svend Lindenberg, Rene Frydman & Bart CJM Fauser. (2022) The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction. Reproductive BioMedicine Online 45:6, pages 1133-1144.
Crossref
Crossref
Liang Hua, Yang Zhe, Yang Jing, Shen Fujin, Chen Jiao & Liu Liu. (2022) Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation. BMC Pregnancy and Childbirth 22:1.
Crossref
Crossref
Nuria Correa, Jesus Cerquides, Josep Lluis Arcos & Rita Vassena. (2022) Supporting first FSH dosage for ovarian stimulation with machine learning. Reproductive BioMedicine Online 45:5, pages 1039-1045.
Crossref
Crossref
Suleiman Ghunaim, Raja Sayegh & Johnny Awwad. 2022. Ovarian Stimulation. Ovarian Stimulation
166
172
.
Zhe Yang, Xuehan Zhao, Xue Hu, Xiangyang Ou, Tailang Yin, Jing Yang & Gengxiang Wu. (2021) Body Mass Index Showed No Impact on the Outcome of In Vitro Fertilization in Progestin-Primed Ovarian Stimulation Protocol. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-5.
Crossref
Crossref
Yubin Li, Yuwei Duan, Xi Yuan, Bing Cai, Yanwen Xu & Yuan Yuan. (2021) A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol. Frontiers in Endocrinology 12.
Crossref
Crossref
E Papaleo, A Revelli, M Costa, M Bertoli, S Zaffagnini, F Tomei, M Manno, A Rebecchi, R Villanacci, V S Vanni, F Cantatore, A Ruffa, D Colia, M Sironi, T Tessari, F Parissone, I Romanello, M Reschini, C Dallagiovanna & E Somigliana. (2021) Do we trust scientific evidence? A multicentre retrospective analysis of first IVF/ICSI cycles before and after the OPTIMIST trial. Human Reproduction 36:5, pages 1367-1375.
Crossref
Crossref
Jori A Leijdekkers, Helen L Torrance, Nienke E Schouten, Theodora C van Tilborg, Simone C Oudshoorn, Ben Willem J Mol, Marinus J C Eijkemans & Frank J M Broekmans. (2020) Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders. Human Reproduction 35:9, pages 1954-1963.
Crossref
Crossref
Colin M Howles. 2020. Patient-Centered Assisted Reproduction. Patient-Centered Assisted Reproduction
23
38
.
Valentina Grisendi & Antonio La Marca. 2020. Textbook of Assisted Reproduction. Textbook of Assisted Reproduction
31
36
.
Ali Abbara, Aaran Patel, Tia Hunjan, Sophie A. Clarke, Germaine Chia, Pei Chia Eng, Maria Phylactou, Alexander N. Comninos, Stuart Lavery, Geoffrey H. Trew, Rehan Salim, Raj S. Rai, Tom W. Kelsey & Waljit S. Dhillo. (2019) FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation. Frontiers in Endocrinology 10.
Crossref
Crossref
Mengchen Zhu, Shanshan Wang, Shanling Yi, Xiaomin Huang, Junan Meng, Li Chen, Haixiang Sun & Jianjun Zhou. (2019) A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF/ICSI cycles. Archives of Gynecology and Obstetrics 300:2, pages 441-446.
Crossref
Crossref
Joana Peñarrubia, Juan Antonio García-Velasco & Jose Landeras. (2019) Modelos predictivos en reproducción asistida: revisión sistemática y análisis crítico. Medicina Reproductiva y Embriología Clínica 6:2-3, pages 63-74.
Crossref
Crossref
Sociedad Española de Ginecología y Obstetricia SEGO. (2019) Estimulación ovárica para fecundación in vitro-inyección intracitoplasmática de espermatozoides en los ciclos con presunción de alta respuesta (2017). Progresos de Obstetricia y Ginecología.
Crossref
Crossref
Antonio La Marca, Christophe Blockeel, Ernesto Bosch, Renato Fanchin, Human M Fatemi, Bart C Fauser, Juan A García-Velasco, Peter Humaidan, Basil C Tarlatzis & Scott M Nelson. (2018) Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Human Reproduction 33:5, pages 982-983.
Crossref
Crossref
Dayong LeeSoo Jin HanSeul Ki KimByung Chul Jee. (2018)
A retrospective analysis of the follicle-stimulating hormone starting dose in expected normal responders undergoing their first
in vitro
fertilization cycle: proposed dose versus empiric dose
. Clinical and Experimental Reproductive Medicine 45:4, pages 183.
Crossref
Crossref
Sumi Thomas, Mousumi Acharya, K Muthukumar, Achamma Chandy, MohanS Kamath & TK Aleyamma. (2018) Effectiveness of anti-mullerian hormone-tailored protocol compared to conventional protocol in women undergoing in vitro fertilization: A randomized controlled trial. Journal of Human Reproductive Sciences 11:1, pages 24.
Crossref
Crossref
Å. Magnusson, L. Nilsson, G. Oleröd, A. Thurin-Kjellberg & C. Bergh. (2017) The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response—a randomized, controlled trial. Human Reproduction 32:4, pages 811-819.
Crossref
Crossref
Adolfo Allegra, Angelo Marino, Aldo Volpes, Francesco Coffaro, Piero Scaglione, Salvatore Gullo & Antonio La Marca. (2017) A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles. Reproductive BioMedicine Online 34:4, pages 429-438.
Crossref
Crossref
Theodora C. van Tilborg, Frank J.M. Broekmans, Madeleine Dólleman, Marinus J.C. Eijkemans, Ben Willem Mol, Joop S.E. Laven & Helen L. Torrance. (2016) Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review. Acta Obstetricia et Gynecologica Scandinavica 95:12, pages 1333-1344.
Crossref
Crossref
Enrico Papaleo, Stefano Zaffagnini, Maria Munaretto, Valeria Stella Vanni, Giorgia Rebonato, Valentina Grisendi, Rossana Di Paola & Antonio La Marca. (2016) Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study. European Journal of Obstetrics & Gynecology and Reproductive Biology 207, pages 94-99.
Crossref
Crossref
Kyoung Yong MoonHoon KimJoong Yeup LeeJung Ryeol LeeByung Chul JeeChang Suk SuhKi Chul KimWon Don LeeJin Ho LimSeok Hyun Kim. (2016) Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation. Clinical and Experimental Reproductive Medicine 43:2, pages 112.
Crossref
Crossref
Jean Luc Pouly, François Olivennes, Nathalie Massin, Médéric Celle, Natacha Caizergues & Francis Contard. (2015) Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study. Reproductive BioMedicine Online 31:3, pages 347-355.
Crossref
Crossref
F. Olivennes, G. Trew, A. Borini, F. Broekmans, P. Arriagada, D.W. Warne & C.M. Howles. (2015) Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa. Reproductive BioMedicine Online 30:3, pages 248-257.
Crossref
Crossref
Jean-Claude EmperaireJean-Claude Emperaire. 2015. Ovulation Stimulation with Gonadotropins. Ovulation Stimulation with Gonadotropins
139
168
.
Nawara M. Hashish & Eman K. Shaeer. (2014) Choosing the optimal dose of human menopausal gonadotropins for ovarian stimulation in ICSI cycles. Middle East Fertility Society Journal 19:2, pages 124-128.
Crossref
Crossref
A. La Marca & S. K. Sunkara. (2013) Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update 20:1, pages 124-140.
Crossref
Crossref
Antonio La Marca, Valentina Grisendi, Simone Giulini, Cindy Argento, Alessandra Tirelli, Giulia Dondi, Enrico Papaleo & Annibale Volpe. (2013) Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count. Journal of Ovarian Research 6:1, pages 11.
Crossref
Crossref
Jean-Claude EmperaireJean-Claude Emperaire. 2013. Pratique de la stimulation ovulatoire par les gonadotrophines. Pratique de la stimulation ovulatoire par les gonadotrophines
143
174
.
A La Marca, E Papaleo, V Grisendi, C Argento, S Giulini & A Volpe. (2012)
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in
in vitro
fertilisation cycles
. BJOG: An International Journal of Obstetrics & Gynaecology 119:10, pages 1171-1179.
Crossref
Crossref
Ariel Weissman & Colin M. Howles. 2012. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives
162
207
.
Juan Balasch. 2012. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives
75
98
.
Zeev Shoham & Colin M. Howles. 2012. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives
51
74
.
Carlo Alviggi, Peter Humaidan & Diego Ezcurra. (2012) Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reproductive Biology and Endocrinology 10:1, pages 9.
Crossref
Crossref
Klaus Fiedler & Diego Ezcurra. (2012) Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reproductive Biology and Endocrinology 10:1, pages 32.
Crossref
Crossref
Luciano G. Nardo, Richard Fleming, Colin M. Howles, Ernesto Bosch, Samir Hamamah, Filippo M. Ubaldi, Jean-Noel Hugues, Adam H. Balen & Scott M. Nelson. (2011) Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reproductive BioMedicine Online 23:2, pages 141-148.
Crossref
Crossref
F Olivennes, CM Howies, A Borini, M Germond, G Trew, M Wikland, F Zegers-Hochschild, H Saunders & V Alam. (2011) Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reproductive BioMedicine Online 22, pages S73-S82.
Crossref
Crossref
S. L. Broer, M. Dolleman, B. C. Opmeer, B. C. Fauser, B. W. Mol & F. J. M. Broekmans. (2010) AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update 17:1, pages 46-54.
Crossref
Crossref
N. la Cour Freiesleben, T.A. Gerds, J.L. Forman, J.D. Silver, A. Nyboe Andersen & B. Popovic-Todorovic. (2011) Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients. Reproductive BioMedicine Online 22:1, pages 50-58.
Crossref
Crossref
Philippe Lehert, Joan C Schertz & Diego Ezcurra. (2010) Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reproductive Biology and Endocrinology 8:1.
Crossref
Crossref
Valerie L. Baker, Barbara Luke, Morton B. Brown, Ruben Alvero, John L. Frattarelli, Rebecca Usadi, David A. Grainger & Alicia Y. Armstrong. (2010) Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertility and Sterility 94:4, pages 1410-1416.
Crossref
Crossref
C.M. Howles, V. Alam, D. Tredway, R. Homburg & D.W. Warne. (2010) Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. Reproductive BioMedicine Online 20:2, pages 182-190.
Crossref
Crossref
P. Devroey, B.C.J.M. Fauser & K. Diedrich. (2009) Approaches to improve the diagnosis and management of infertility. Human Reproduction Update 15:4, pages 391-408.
Crossref
Crossref
F Olivennes, CM Howles, A Borini, M Germond, G Trew, M Wikland, F Zegers-Hochschild, H Saunders & V Alam. (2009) Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reproductive BioMedicine Online 18:2, pages 195-204.
Crossref
Crossref
Amr A. Azim & Owen K. Davis. 2009. Biennial Review of Infertility. Biennial Review of Infertility
37
80
.
S. M. Nelson, R. W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose & R. Fleming. (2008) Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction 24:4, pages 867-875.
Crossref
Crossref
F. Olivennes. (2008) L’étude CONSORT : vers un choix scientifique de la dose de départ de gonadotrophines en stimulation ovarienne. Gynécologie Obstétrique & Fertilité 36, pages 2-3.
Crossref
Crossref
Biljana Popovic Todorovic & Paul Devroey. 2010. Infertility and Assisted Reproduction. Infertility and Assisted Reproduction
747
758
.
Jean-Noël Hugues. (2008) Influence de l’excès pondéral sur les approches d’induction de l’ovulation. Bulletin de l'Académie Nationale de Médecine 192:4, pages 661-671.
Crossref
Crossref
B.C.J.M. Fauser, K. Diedrich & P. Devroey. (2008) Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Human Reproduction Update 14:1, pages 1-14.
Crossref
Crossref